Peptide Research Library

A research-focused overview of Tesamorelin, a stabilized GHRH analog studied for its effects on growth hormone signaling, IGF-1, and visceral fat biology across preclinical and clinical research.

A research-focused overview of Ipamorelin, a selective pentapeptide ghrelin-receptor agonist studied for clean, pulsatile growth hormone release and its hallmark neuroendocrine selectivity across preclinical research.

A research-focused overview of Sermorelin, the GHRH(1-29) fragment studied as a tool for stimulating endogenous, pulsatile growth hormone release through the pituitary across preclinical and clinical research.

A research-focused overview of CJC-1295 DAC, a long-acting GHRH analog that uses albumin bioconjugation to extend its half-life and produce sustained growth hormone and IGF-1 signaling in preclinical and clinical research.

A research-focused overview of CJC-1295 (no DAC), also known as Modified GRF(1-29), a short-acting GHRH analog studied for its ability to drive discrete growth hormone pulses and IGF-1 signaling in preclinical research.

A research-focused overview of MK-677 (Ibutamoren), an orally active, non-peptide ghrelin receptor agonist studied for sustained growth hormone and IGF-1 axis signaling across preclinical and clinical research.

A research-focused overview of IGF-1 LR3 (Long R3 IGF-1), a potent, long-acting IGF-1 receptor agonist engineered to escape IGF-binding proteins and studied for anabolic and metabolic signaling.

A research-focused overview of PEG-MGF, the pegylated form of mechano growth factor, an IGF-1Ec splice variant studied for satellite cell activation, local muscle repair signaling, and pharmacokinetics.

A research-focused overview comparing GHRP-2 and GHRP-6, two synthetic growth hormone-releasing peptides studied as ghrelin-mimetic secretagogues acting at the GHS-R1a receptor to drive pulsatile GH release across preclinical and clinical research.

A research-focused overview of human growth hormone (somatotropin), summarizing its 191-amino-acid structure, growth hormone receptor and JAK-STAT signaling, the IGF-1 axis, pulsatile secretion, and the endpoints used to study body composition and metabolic outcomes in preclinical and clinical settings.

A research-focused overview of BPC-157, a stable pentadecapeptide derived from gastric juice, studied for cytoprotection, angiogenic signaling, and tissue repair across preclinical injury models.